{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:27:52Z","timestamp":1786933672629,"version":"build-2736575974"},"reference-count":18,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.715","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T22:20:49Z","timestamp":1510784449000},"page":"715-721","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of a rat model of moderate liver dysfunction based on alpha-naphthylisothiocyanate-induced cholestasis"],"prefix":"10.2131","volume":"42","author":[{"given":"Melanie K.","family":"Bothe","sequence":"first","affiliation":[{"name":"Fresenius Kabi Deutschland GmbH, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Meyer","sequence":"additional","affiliation":[{"name":"Fresenius Kabi Deutschland GmbH, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Mueller","sequence":"additional","affiliation":[{"name":"Biocrates Life Sciences AG, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Queudot","sequence":"additional","affiliation":[{"name":"Charles River Laboratories, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Roger","sequence":"additional","affiliation":[{"name":"Charles River Laboratories, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Harleman","sequence":"additional","affiliation":[{"name":"Fresenius Kabi Deutschland GmbH, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Westphal","sequence":"additional","affiliation":[{"name":"Fresenius Kabi Deutschland GmbH, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aoki, Y., Suzuki, H. and Itoh, H. (1986): Changes in polyamine metabolism in rat liver after oral administration of alpha-naphthylisothiocyanate. J. Toxicol. Sci., <b>11<\/b>, 95-104.","DOI":"10.2131\/jts.11.95"},{"key":"2","unstructured":"Brown, R.S.Jr. (2000): Predicting outcome of transplantation for cholestatic liver disease: Child-Pugh or Mayo risk score? Liver Transpl.,<b> 6<\/b>, 759-761."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chisholm, J.W. and Dolphin, P.J. (1996): Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis. J. Lipid. Res., <b>37<\/b>, 1086-1098.","DOI":"10.1016\/S0022-2275(20)42018-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Glaser, S.S., Onori, P., Wise, C., Yang, F., Marzioni, M., Alvaro, D., Franchitto, A., Mancinelli, R., Alpini, G., Munshi, M.K. and Gaudio, E. (2010): Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.Dig. Liver Dis., <b>42<\/b>, 245-252.","DOI":"10.1016\/j.dld.2010.01.008"},{"key":"5","unstructured":"Goldfarb, S., Singer, E.J. and Popper, H. (1962): Experimental cholangitis due to alpha-naphthyl-isothiocyanate (ANIT). Am. J. Pathol., <b>40<\/b>, 685-698."},{"key":"6","unstructured":"Horiuchi, T., Ohtsubo, K. and Saito, M. (1978): Development of resistance to hepatotoxic effect of furylfuramide by pretreatment with its subnecrotic doses and carbon tetrachloride. Jpn. J. Exp. Med., <b>48<\/b>, 27-33."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kinny-K\u00f6ster, B., Bartels, M., Becker, S., Scholz, M., Thiery, J., Ceglarek, U. and Kaiser, T. (2016): Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease. PloS One,<b> 11<\/b>, e0159205.","DOI":"10.1371\/journal.pone.0159205"},{"key":"8","unstructured":"Leonard, T.B., Neptun, D.A. and Popp, J.A. (1984): Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver. Am. J. Pathol., <b>116<\/b>, 262-269."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lesage, G., Glaser, S., Ueno, Y., Alvaro, D., Baiocchi, L., Kanno, N., Phinizy, J.L., Francis, H. and Alpini, G. (2001): Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol., <b>281<\/b>, G182-190.","DOI":"10.1152\/ajpgi.2001.281.1.G182"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Mager, D.R., Wykes, L.J., Roberts, E.A., Ball, R.O. and Pencharz, P.B. (2006): Branched-chain amino acid needs in children with mild-to-moderate chronic cholestatic liver disease. J. Nutr., <b>136<\/b>, 133-139.","DOI":"10.1093\/jn\/136.1.133"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ouchi, K., Matsubara, S., Fukuhara, K. and Matsuno, S. (1989): Plasma amino acid abnormalities in liver disease: comparative analysis of idiopathic portal hypertension, extrahepatic portal occlusion and liver cirrhosis. Tohoku J. Exp. Med., <b>158<\/b>, 171-178.","DOI":"10.1620\/tjem.158.171"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Peng, Y., Qi, X. and Guo, X. (2016): Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine, <b>95<\/b>, e2877.","DOI":"10.1097\/MD.0000000000002877"},{"key":"13","unstructured":"Roberts, E., Ahluwalia, M.B., Lee, G., Chan, C., Sarma, D.S. and Farber, E. (1983): Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Cancer Res., <b>43<\/b>, 28-34."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garay, E.A. (2003): Cholestasis: human disease and experimental animal models. Ann. Hepatol., <b>2<\/b>, 150-158.","DOI":"10.1016\/S1665-2681(19)32126-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Saitoh, W., Yamauchi, S., Watanabe, K., Takasaki, W. and Mori, K. (2014): Metabolomic analysis of arginine metabolism in acute hepatic injury in rats. J. Toxicol. Sci., <b>39<\/b>, 41-50.","DOI":"10.2131\/jts.39.41"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Tanaka, Y., Aleksunes, L.M., Cui, Y.J. and Klaassen, C.D. (2009): ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. Toxicol. Sci., <b>108<\/b>, 247-257.","DOI":"10.1093\/toxsci\/kfp020"},{"key":"17","unstructured":"Uryvaeva, I.V. and Faktor, V.M. (1976a): [Relationship between cell division and function. Resistance of the liver to toxic effect of CCL4 after partial hepatectomy]. Tsitologiia, <b>18<\/b>, 1354-1359."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Uryvaeva, I.V. and Faktor, V.M. (1976b): [Resistance of regenerating liver to hepatotoxins]. Biull. Eksp. Biol. Med., <b>81<\/b>, 283-285.","DOI":"10.1007\/BF00804907"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_715\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T11:44:08Z","timestamp":1659872648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/6\/42_715\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.715","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}